start_structures/Ligand_Substrate/Ligand_Complex_Stripped/C8Y_6B1F.pdb
 OpenBabel08222315203D

 29 32  0  0  1  0  0  0  0  0999 V2000
   -6.2780    2.1940    3.1600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8730    0.8040    3.4320 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.4640    0.4510    2.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9860   -0.6240    3.3560 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7710   -0.1910    2.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0840   -0.2350    3.2130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1990   -2.9580   -0.9900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8150   -0.4430    0.1050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3850   -1.5820   -0.5100 S   0  0  2  0  0  0  0  0  0  0  0  0
   -9.2170   -1.7450   -0.3870 S   0  0  2  0  0  0  0  0  0  0  0  0
   -9.2980   -0.6150   -1.6110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9880   -2.5200   -0.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3130   -1.3200    0.4250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.8540   -1.5080   -1.6880 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7500   -1.3900    0.1890 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2250   -2.4170    0.5530 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2890   -2.2900    1.1720 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1800   -1.6420    1.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8730   -1.9170    2.5010 C   0  0  2  0  0  0  0  0  0  0  0  0
  -11.8170   -1.8740    2.3400 C   0  0  2  0  0  0  0  0  0  0  0  0
  -12.9400   -0.8280    2.1490 C   0  0  2  0  0  0  0  0  0  0  0  0
  -12.4310    0.6350    1.9640 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5710    1.0640    3.1190 C   0  0  1  0  0  0  0  0  0  0  0  0
  -12.0220    1.0370    4.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.3810    1.0170    5.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3750    0.0600    3.0480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1330    0.5070    2.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7950    1.6110    2.2950 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6440   -1.3890    3.2410 C   0  0  1  0  0  0  0  0  0  0  0  0
  2  1  1  6  0  0  0
  3  4  2  0  0  0  0
  3  2  1  0  0  0  0
  5  6  1  0  0  0  0
  5  2  1  0  0  0  0
  6 27  1  0  0  0  0
  8 10  1  0  0  0  0
  8 13  1  0  0  0  0
  9  7  1  6  0  0  0
  9 11  1  0  0  0  0
  9 13  1  0  0  0  0
  9 15  1  0  0  0  0
 10 12  1  6  0  0  0
 10 14  1  0  0  0  0
 10 16  1  0  0  0  0
 14 11  1  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 19 17  1  6  0  0  0
 19 21  1  0  0  0  0
 19 29  1  0  0  0  0
 20 18  1  6  0  0  0
 20 21  1  0  0  0  0
 20 29  1  0  0  0  0
 21 22  1  1  0  0  0
 22 23  1  0  0  0  0
 23 24  1  1  0  0  0
 23 26  1  0  0  0  0
 24 25  3  0  0  0  0
 26 27  1  0  0  0  0
 27 28  2  0  0  0  0
 29 26  1  1  0  0  0
M  END
>  <HEADER>
    HYDROLASE/HYDROLASE INHIBITOR           18-SEP-17   6B1F              

>  <TITLE>
    CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 4234 BY     
   2 SOAKING                                                              

>  <COMPND>
    MOL_ID: 1;                                                            
   2 MOLECULE: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC;                 
   3 CHAIN: A, B;                                                         
   4 SYNONYM: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC-1;                
   5 EC: 3.5.2.6;                                                         
   6 ENGINEERED: YES                                                      

>  <SOURCE>
    MOL_ID: 1;                                                            
   2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE;                          
   3 ORGANISM_TAXID: 573;                                                 
   4 GENE: BLA, KPC, KPC1;                                                
   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
   6 EXPRESSION_SYSTEM_TAXID: 562                                         

>  <KEYWDS>
    INHIBITOR, COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX  

>  <EXPDTA>
    X-RAY DIFFRACTION                                                     

>  <AUTHOR>
    F.VAN DEN AKKER,N.Q.NGUYEN                                            

>  <REVDAT>
   1   01-AUG-18 6B1F    0                                                

>  <JRNL>
      AUTH   K.M.PAPP-WALLACE,N.Q.NGUYEN,M.R.JACOBS,C.R.BETHEL,           
      AUTH 2 M.D.BARNES,V.KUMAR,S.BAJAKSOUZIAN,S.D.RUDIN,P.N.RATHER,      
      AUTH 3 S.BHAVSAR,T.RAVIKUMAR,P.K.DESHPANDE,V.PATIL,R.YEOLE,         
      AUTH 4 S.S.BHAGWAT,M.V.PATEL,F.VAN DEN AKKER,R.A.BONOMO             
      TITL   STRATEGIC APPROACHES TO OVERCOME RESISTANCE AGAINST          
      TITL 2 GRAM-NEGATIVE PATHOGENS USING BETA-LACTAMASE INHIBITORS AND  
      TITL 3 BETA-LACTAM ENHANCERS: ACTIVITY OF THREE NOVEL               
      TITL 4 DIAZABICYCLOOCTANES WCK 5153, ZIDEBACTAM (WCK 5107), AND WCK 
      TITL 5 4234.                                                        
      REF    J. MED. CHEM.                 V.  61  4067 2018              
      REFN                   ISSN 1520-4804                               
      PMID   29627985                                                     
      DOI    10.1021/ACS.JMEDCHEM.8B00091                                 

>  <REMARK>
   2                                                                      
   2 RESOLUTION.    1.44 ANGSTROMS.                                       
   3                                                                      
   3 REFINEMENT.                                                          
   3   PROGRAM     : REFMAC 5.8.0135                                      
   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
   3               : NICHOLLS,WINN,LONG,VAGIN                             
   3                                                                      
   3    REFINEMENT TARGET : NULL                                          
   3                                                                      
   3  DATA USED IN REFINEMENT.                                            
   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.44                           
   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 31.78                          
   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
   3   COMPLETENESS FOR RANGE        (%) : 91.6                           
   3   NUMBER OF REFLECTIONS             : 64530                          
   3                                                                      
   3  FIT TO DATA USED IN REFINEMENT.                                     
   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
   3   R VALUE     (WORKING + TEST SET) : 0.151                           
   3   R VALUE            (WORKING SET) : 0.150                           
   3   FREE R VALUE                     : 0.174                           
   3   FREE R VALUE TEST SET SIZE   (%) : 5.000                           
   3   FREE R VALUE TEST SET COUNT      : 3406                            
   3                                                                      
   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
   3   TOTAL NUMBER OF BINS USED           : 20                           
   3   BIN RESOLUTION RANGE HIGH       (A) : 1.44                         
   3   BIN RESOLUTION RANGE LOW        (A) : 1.48                         
   3   REFLECTION IN BIN     (WORKING SET) : 3090                         
   3   BIN COMPLETENESS (WORKING+TEST) (%) : 59.59                        
   3   BIN R VALUE           (WORKING SET) : 0.2200                       
   3   BIN FREE R VALUE SET COUNT          : 134                          
   3   BIN FREE R VALUE                    : 0.2130                       
   3                                                                      
   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
   3   PROTEIN ATOMS            : 3977                                    
   3   NUCLEIC ACID ATOMS       : 0                                       
   3   HETEROGEN ATOMS          : 57                                      
   3   SOLVENT ATOMS            : 493                                     
   3                                                                      
   3  B VALUES.                                                           
   3   FROM WILSON PLOT           (A**2) : NULL                           
   3   MEAN B VALUE      (OVERALL, A**2) : 12.08                          
   3   OVERALL ANISOTROPIC B VALUE.                                       
   3    B11 (A**2) : 0.00000                                              
   3    B22 (A**2) : 0.00000                                              
   3    B33 (A**2) : 0.00000                                              
   3    B12 (A**2) : 0.00000                                              
   3    B13 (A**2) : 0.00000                                              
   3    B23 (A**2) : 0.00000                                              
   3                                                                      
   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
   3   ESU BASED ON R VALUE                            (A): 0.072         
   3   ESU BASED ON FREE R VALUE                       (A): 0.070         
   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.044         
   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.123         
   3                                                                      
   3 CORRELATION COEFFICIENTS.                                            
   3   CORRELATION COEFFICIENT FO-FC      : 0.969                         
   3   CORRELATION COEFFICIENT FO-FC FREE : 0.957                         
   3                                                                      
   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
   3   BOND LENGTHS REFINED ATOMS        (A):  4221 ; 0.010 ; 0.020       
   3   BOND LENGTHS OTHERS               (A):  4036 ; 0.002 ; 0.020       
   3   BOND ANGLES REFINED ATOMS   (DEGREES):  5753 ; 2.167 ; 1.992       
   3   BOND ANGLES OTHERS          (DEGREES):  9275 ; 1.015 ; 3.009       
   3   TORSION ANGLES, PERIOD 1    (DEGREES):   537 ; 6.055 ; 5.000       
   3   TORSION ANGLES, PERIOD 2    (DEGREES):   169 ;33.623 ;23.195       
   3   TORSION ANGLES, PERIOD 3    (DEGREES):   660 ;11.809 ;15.000       
   3   TORSION ANGLES, PERIOD 4    (DEGREES):    34 ;13.354 ;15.000       
   3   CHIRAL-CENTER RESTRAINTS       (A**3):   666 ; 0.283 ; 0.200       
   3   GENERAL PLANES REFINED ATOMS      (A):  4759 ; 0.006 ; 0.021       
   3   GENERAL PLANES OTHERS             (A):   943 ; 0.001 ; 0.020       
   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
   3                                                                      
   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
   3                                                                      
   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
   3                                                                      
   3  NCS RESTRAINTS STATISTICS                                           
   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
   3                                                                      
   3  TLS DETAILS                                                         
   3   NUMBER OF TLS GROUPS  : NULL                                       
   3                                                                      
   3  BULK SOLVENT MODELLING.                                             
   3   METHOD USED : NULL                                                 
   3   PARAMETERS FOR MASK CALCULATION                                    
   3   VDW PROBE RADIUS   : 1.20                                          
   3   ION PROBE RADIUS   : 0.80                                          
   3   SHRINKAGE RADIUS   : 0.80                                          
   3                                                                      
   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
   3  POSITIONS U VALUES : REFINED INDIVIDUALLY                           
   4                                                                      
   4 6B1F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
 100                                                                      
 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-17.                  
 100 THE DEPOSITION ID IS D_1000230134.                                   
 200                                                                      
 200 EXPERIMENTAL DETAILS                                                 
 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
 200  DATE OF DATA COLLECTION        : 17-MAY-15                          
 200  TEMPERATURE           (KELVIN) : 100                                
 200  PH                             : 4.0                                
 200  NUMBER OF CRYSTALS USED        : 1                                  
 200                                                                      
 200  SYNCHROTRON              (Y/N) : Y                                  
 200  RADIATION SOURCE               : SSRL                               
 200  BEAMLINE                       : BL7-1                              
 200  X-RAY GENERATOR MODEL          : NULL                               
 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
 200  WAVELENGTH OR RANGE        (A) : 1.12708                            
 200  MONOCHROMATOR                  : NULL                               
 200  OPTICS                         : NULL                               
 200                                                                      
 200  DETECTOR TYPE                  : CCD                                
 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315                   
 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
 200  DATA SCALING SOFTWARE          : XDS                                
 200                                                                      
 200  NUMBER OF UNIQUE REFLECTIONS   : 67950                              
 200  RESOLUTION RANGE HIGH      (A) : 1.440                              
 200  RESOLUTION RANGE LOW       (A) : 37.240                             
 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
 200                                                                      
 200 OVERALL.                                                             
 200  COMPLETENESS FOR RANGE     (%) : 91.6                               
 200  DATA REDUNDANCY                : 2.000                              
 200  R MERGE                    (I) : NULL                               
 200  R SYM                      (I) : NULL                               
 200  <I/SIGMA(I)> FOR THE DATA SET  : 13.1000                            
 200                                                                      
 200 IN THE HIGHEST RESOLUTION SHELL.                                     
 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL                     
 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     
 200  COMPLETENESS FOR SHELL     (%) : NULL                               
 200  DATA REDUNDANCY IN SHELL       : NULL                               
 200  R MERGE FOR SHELL          (I) : NULL                               
 200  R SYM FOR SHELL            (I) : NULL                               
 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
 200                                                                      
 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
 200 SOFTWARE USED: REFMAC                                                
 200 STARTING MODEL: NULL                                                 
 200                                                                      
 200 REMARK: NULL                                                         
 280                                                                      
 280 CRYSTAL                                                              
 280 SOLVENT CONTENT, VS   (%): 34.16                                     
 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87                     
 280                                                                      
 280 CRYSTALLIZATION CONDITIONS: 20% PEG 6000, 100 MM CITRATE PH 4.0,     
 280  100 MM KSCN, AND 10 MM CDCL2. CRYSTAL SOAKED FOR 3HR IN 10MM WCK    
 280  4234, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K               
 290                                                                      
 290 CRYSTALLOGRAPHIC SYMMETRY                                            
 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1                              
 290                                                                      
 290      SYMOP   SYMMETRY                                                
 290     NNNMMM   OPERATOR                                                
 290       1555   X,Y,Z                                                   
 290                                                                      
 290     WHERE NNN -> OPERATOR NUMBER                                     
 290           MMM -> TRANSLATION VECTOR                                  
 290                                                                      
 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
 290 RELATED MOLECULES.                                                   
 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
 290                                                                      
 290 REMARK: NULL                                                         
 300                                                                      
 300 BIOMOLECULE: 1, 2                                                    
 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
 300 BURIED SURFACE AREA.                                                 
 350                                                                      
 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
 350                                                                      
 350 BIOMOLECULE: 1                                                       
 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
 350 SOFTWARE USED: PISA                                                  
 350 APPLY THE FOLLOWING TO CHAINS: A                                     
 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
 350                                                                      
 350 BIOMOLECULE: 2                                                       
 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
 350 SOFTWARE USED: PISA                                                  
 350 APPLY THE FOLLOWING TO CHAINS: B                                     
 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
 465                                                                      
 465 MISSING RESIDUES                                                     
 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
 465                                                                      
 465   M RES C SSSEQI                                                     
 465     ALA B    22                                                      
 465     THR B    23                                                      
 465     ALA B    24                                                      
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
 500                                                                      
 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
 500                                                                      
 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
 500   OG   SER A    69     OAB  C8Y A   301              2.18            
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: COVALENT BOND ANGLES                                       
 500                                                                      
 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
 500                                                                      
 500 STANDARD TABLE:                                                      
 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
 500                                                                      
 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
 500                                                                      
 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
 500    ARG A 266   NE  -  CZ  -  NH2 ANGL. DEV. =   3.3 DEGREES          
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: TORSION ANGLES                                             
 500                                                                      
 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
 500                                                                      
 500 STANDARD TABLE:                                                      
 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
 500                                                                      
 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
 500                                                                      
 500  M RES CSSEQI        PSI       PHI                                   
 500    CYS A  68     -141.78     50.29                                   
 500    ARG A 219     -124.36   -116.43                                   
 500    CYS B  68     -140.85     50.58                                   
 500    ARG B 219     -122.97   -111.75                                   
 500                                                                      
 500 REMARK: NULL                                                         
 525                                                                      
 525 SOLVENT                                                              
 525                                                                      
 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
 525 NUMBER; I=INSERTION CODE):                                           
 525                                                                      
 525  M RES CSSEQI                                                        
 525    HOH A 658        DISTANCE =  6.28 ANGSTROMS                       
 800                                                                      
 800 SITE                                                                 
 800 SITE_IDENTIFIER: AC1                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue C8Y A 301                 
 800                                                                      
 800 SITE_IDENTIFIER: AC2                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue CIT A 302                 
 800                                                                      
 800 SITE_IDENTIFIER: AC3                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue EDO A 303                 
 800                                                                      
 800 SITE_IDENTIFIER: AC4                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue EDO B 302                 
 800                                                                      
 800 SITE_IDENTIFIER: AC5                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue EDO B 303                 
 800                                                                      
 800 SITE_IDENTIFIER: AC6                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for Di-peptide C8Y B 301 and SER B    
 800  69                                                                  

>  <DBREF>
 6B1F A   22   291  UNP    Q9F663   BLKPC_KLEPN     22    289             
 6B1F B   22   291  UNP    Q9F663   BLKPC_KLEPN     22    289             

>  <SEQRES>
   1 A  268  ALA THR ALA LEU THR ASN LEU VAL ALA GLU PRO PHE ALA          
   2 A  268  LYS LEU GLU GLN ASP PHE GLY GLY SER ILE GLY VAL TYR          
   3 A  268  ALA MET ASP THR GLY SER GLY ALA THR VAL SER TYR ARG          
   4 A  268  ALA GLU GLU ARG PHE PRO LEU CYS SER SER PHE LYS GLY          
   5 A  268  PHE LEU ALA ALA ALA VAL LEU ALA ARG SER GLN GLN GLN          
   6 A  268  ALA GLY LEU LEU ASP THR PRO ILE ARG TYR GLY LYS ASN          
   7 A  268  ALA LEU VAL PRO TRP SER PRO ILE SER GLU LYS TYR LEU          
   8 A  268  THR THR GLY MET THR VAL ALA GLU LEU SER ALA ALA ALA          
   9 A  268  VAL GLN TYR SER ASP ASN ALA ALA ALA ASN LEU LEU LEU          
  10 A  268  LYS GLU LEU GLY GLY PRO ALA GLY LEU THR ALA PHE MET          
  11 A  268  ARG SER ILE GLY ASP THR THR PHE ARG LEU ASP ARG TRP          
  12 A  268  GLU LEU GLU LEU ASN SER ALA ILE PRO GLY ASP ALA ARG          
  13 A  268  ASP THR SER SER PRO ARG ALA VAL THR GLU SER LEU GLN          
  14 A  268  LYS LEU THR LEU GLY SER ALA LEU ALA ALA PRO GLN ARG          
  15 A  268  GLN GLN PHE VAL ASP TRP LEU LYS GLY ASN THR THR GLY          
  16 A  268  ASN HIS ARG ILE ARG ALA ALA VAL PRO ALA ASP TRP ALA          
  17 A  268  VAL GLY ASP LYS THR GLY THR CYS GLY VAL TYR GLY THR          
  18 A  268  ALA ASN ASP TYR ALA VAL VAL TRP PRO THR GLY ARG ALA          
  19 A  268  PRO ILE VAL LEU ALA VAL TYR THR ARG ALA PRO ASN LYS          
  20 A  268  ASP ASP LYS HIS SER GLU ALA VAL ILE ALA ALA ALA ALA          
  21 A  268  ARG LEU ALA LEU GLU GLY LEU GLY                              
   1 B  268  ALA THR ALA LEU THR ASN LEU VAL ALA GLU PRO PHE ALA          
   2 B  268  LYS LEU GLU GLN ASP PHE GLY GLY SER ILE GLY VAL TYR          
   3 B  268  ALA MET ASP THR GLY SER GLY ALA THR VAL SER TYR ARG          
   4 B  268  ALA GLU GLU ARG PHE PRO LEU CYS SER SER PHE LYS GLY          
   5 B  268  PHE LEU ALA ALA ALA VAL LEU ALA ARG SER GLN GLN GLN          
   6 B  268  ALA GLY LEU LEU ASP THR PRO ILE ARG TYR GLY LYS ASN          
   7 B  268  ALA LEU VAL PRO TRP SER PRO ILE SER GLU LYS TYR LEU          
   8 B  268  THR THR GLY MET THR VAL ALA GLU LEU SER ALA ALA ALA          
   9 B  268  VAL GLN TYR SER ASP ASN ALA ALA ALA ASN LEU LEU LEU          
  10 B  268  LYS GLU LEU GLY GLY PRO ALA GLY LEU THR ALA PHE MET          
  11 B  268  ARG SER ILE GLY ASP THR THR PHE ARG LEU ASP ARG TRP          
  12 B  268  GLU LEU GLU LEU ASN SER ALA ILE PRO GLY ASP ALA ARG          
  13 B  268  ASP THR SER SER PRO ARG ALA VAL THR GLU SER LEU GLN          
  14 B  268  LYS LEU THR LEU GLY SER ALA LEU ALA ALA PRO GLN ARG          
  15 B  268  GLN GLN PHE VAL ASP TRP LEU LYS GLY ASN THR THR GLY          
  16 B  268  ASN HIS ARG ILE ARG ALA ALA VAL PRO ALA ASP TRP ALA          
  17 B  268  VAL GLY ASP LYS THR GLY THR CYS GLY VAL TYR GLY THR          
  18 B  268  ALA ASN ASP TYR ALA VAL VAL TRP PRO THR GLY ARG ALA          
  19 B  268  PRO ILE VAL LEU ALA VAL TYR THR ARG ALA PRO ASN LYS          
  20 B  268  ASP ASP LYS HIS SER GLU ALA VAL ILE ALA ALA ALA ALA          
  21 B  268  ARG LEU ALA LEU GLU GLY LEU GLY                              

>  <HET>
 C8Y  A 301      23                                                       
 CIT  A 302      13                                                       
 EDO  A 303       4                                                       
 C8Y  B 301      23                                                       
 EDO  B 302       4                                                       
 EDO  B 303       4                                                       

>  <HETNAM>
     C8Y (2S,5R)-1-FORMYL-5-[(SULFOOXY)AMINO]PIPERIDINE-2-                
   2 C8Y  CARBONITRILE                                                    
     CIT CITRIC ACID                                                      
     EDO 1,2-ETHANEDIOL                                                   

>  <HETSYN>
     C8Y OPEN FORM - WCK 4234                                             
     EDO ETHYLENE GLYCOL                                                  

>  <FORMUL>
   3  C8Y    2(C7 H11 N3 O5 S)                                            
   4  CIT    C6 H8 O7                                                     
   5  EDO    3(C2 H6 O2)                                                  
   9  HOH   *493(H2 O)                                                    

>  <HELIX>
   1 AA1 LEU A   25  GLY A   41  1                                  17    
   2 AA2 SER A   70  GLN A   86  1                                  17    
   3 AA3 GLY A   88  ASP A   91  5                                   4    
   4 AA4 GLY A   97  LEU A  101  5                                   5    
   5 AA5 ILE A  107  TYR A  111  5                                   5    
   6 AA6 VAL A  118  TYR A  128  1                                  11    
   7 AA7 ASP A  130  GLY A  142  1                                  13    
   8 AA8 GLY A  142  ILE A  154  1                                  13    
   9 AA9 LEU A  166  SER A  170  5                                   5    
  10 AB1 SER A  181  LEU A  194  1                                  14    
  11 AB2 ALA A  199  GLY A  212  1                                  14    
  12 AB3 ARG A  219  VAL A  224  5                                   6    
  13 AB4 SER A  275  GLY A  289  1                                  15    
  14 AB5 THR B   26  GLY B   41  1                                  16    
  15 AB6 SER B   70  GLN B   84  1                                  15    
  16 AB7 GLY B   97  LEU B  101  5                                   5    
  17 AB8 SER B  105  TYR B  111  1                                   7    
  18 AB9 VAL B  118  TYR B  128  1                                  11    
  19 AC1 ASP B  130  LEU B  141  1                                  12    
  20 AC2 GLY B  143  ILE B  154  1                                  12    
  21 AC3 LEU B  166  SER B  170  5                                   5    
  22 AC4 SER B  181  LEU B  194  1                                  14    
  23 AC5 ALA B  199  GLY B  212  1                                  14    
  24 AC6 ARG B  219  VAL B  224  5                                   6    
  25 AC7 SER B  275  GLY B  289  1                                  15    

>  <SHEET>
   1 AA1 5 THR A  56  TYR A  59  0                                        
   2 AA1 5 SER A  43  ASP A  50 -1  N  VAL A  46   O  TYR A  59           
   3 AA1 5 ILE A 259  ARG A 266 -1  O  TYR A 264   N  GLY A  45           
   4 AA1 5 ALA A 244  TRP A 251 -1  N  VAL A 250   O  ILE A 259           
   5 AA1 5 ALA A 229  THR A 236 -1  N  ALA A 229   O  TRP A 251           
   1 AA2 2 PHE A  65  PRO A  66  0                                        
   2 AA2 2 THR A 179  SER A 180 -1  O  SER A 180   N  PHE A  65           
   1 AA3 2 PRO A  93  ILE A  94  0                                        
   2 AA3 2 MET A 116  THR A 117 -1  O  MET A 116   N  ILE A  94           
   1 AA4 5 THR B  56  TYR B  59  0                                        
   2 AA4 5 SER B  43  ASP B  50 -1  N  VAL B  46   O  TYR B  59           
   3 AA4 5 ILE B 259  ARG B 266 -1  O  TYR B 264   N  GLY B  45           
   4 AA4 5 ALA B 244  TRP B 251 -1  N  ASP B 246   O  VAL B 263           
   5 AA4 5 ALA B 229  THR B 236 -1  N  GLY B 235   O  ASN B 245           
   1 AA5 2 PHE B  65  PRO B  66  0                                        
   2 AA5 2 THR B 179  SER B 180 -1  O  SER B 180   N  PHE B  65           
   1 AA6 2 PRO B  93  ILE B  94  0                                        
   2 AA6 2 MET B 116  THR B 117 -1  O  MET B 116   N  ILE B  94           

>  <SSBOND>
   1 CYS A   68    CYS A  237                          1555   1555  2.06  
   2 CYS B   68    CYS B  237                          1555   1555  2.08  

>  <LINK>
       OG  SER A  69                 CAG C8Y A 301     1555   1555  1.33  
       OG  SER B  69                 CAG C8Y B 301     1555   1555  1.34  

>  <CISPEP>
   1 GLU A  165    LEU A  166          0         6.29                     
   2 GLU B  165    LEU B  166          0         6.32                     

>  <SITE>
   1 AC1 15 CYS A  68  SER A  69  TRP A 104  SER A 129                    
   2 AC1 15 ASN A 131  LEU A 166  ASN A 169  THR A 215                    
   3 AC1 15 LYS A 233  THR A 234  GLY A 235  THR A 236                    
   4 AC1 15 HOH A 407  HOH A 503  HOH A 518                               
   1 AC2 15 TYR A  96  GLY A  97  LYS A  98  ASN A  99                    
   2 AC2 15 ALA A 100  HOH A 405  HOH A 430  HOH A 470                    
   3 AC2 15 HOH A 476  HOH A 514  ARG B  95  ARG B 163                    
   4 AC2 15 ARG B 177  EDO B 303  HOH B 413                               
   1 AC3  6 ALA A 123  ALA A 124  GLN A 127  TYR A 128                    
   2 AC3  6 PRO A 173  HOH A 472                                          
   1 AC4  6 ALA B 123  ALA B 124  GLN B 127  TYR B 128                    
   2 AC4  6 PRO B 173  HOH B 450                                          
   1 AC5  7 CIT A 302  HOH A 405  PRO B  93  THR B 114                    
   2 AC5  7 GLY B 115  ARG B 177  HOH B 417                               
   1 AC6 17 LEU B  67  CYS B  68  SER B  70  PHE B  71                    
   2 AC6 17 LYS B  72  TRP B 104  SER B 129  ASN B 131                    
   3 AC6 17 ASN B 169  THR B 215  LYS B 233  THR B 234                    
   4 AC6 17 GLY B 235  THR B 236  HOH B 405  HOH B 445                    
   5 AC6 17 HOH B 550                                                     

>  <ORIGX1>
      1.000000  0.000000  0.000000        0.00000                         

>  <ORIGX2>
      0.000000  1.000000  0.000000        0.00000                         

>  <ORIGX3>
      0.000000  0.000000  1.000000        0.00000                         

>  <SCALE1>
      0.028952  0.002661  0.000133        0.00000                         

>  <SCALE2>
      0.000000  0.026828  0.001101        0.00000                         

>  <SCALE3>
      0.000000  0.000000  0.012155        0.00000                         

>  <MASTER>
      333    0    6   25   18    0   19    6 4527    2   77   42          

$$$$
